Authors


Shikhar Khurana, MD

Latest:

Navigating Treatment Decision-Making in Multiple Sclerosis

In a paradigm with many options, once multiple sclerosis is confirmed as a patient’s diagnosis, physicians are left with 1 question: What do we choose for long-term treatment?


Emmanuel C. Obusez, MD

Latest:

Advanced Imaging for Extended Stroke Treatment

With many patients presenting with an unknown time of last known well, establishing a tissue window using advanced imaging techniques may allow for more effective intervention and better outcomes.


Prachi Mehndiratta, MBBS, FAHA

Latest:

Preventing Secondary Stroke: Practical Application of Updated Guidelines

Experts provide a summary of the management of commonly encountered risk factors for secondary ischemic stroke and transient ischemic attack based on the newly published 2021 AHA/ASA recommendations.


Richard Lewis, MD

Latest:

A Clinical Preview of 2024 for Neuromuscular Disease: Richard Lewis, MD

The professor of neurology at Cedars-Sinai Medical Center shared his thoughts on potential therapies that expand management care options for patients with neuromuscular disease, in particularly for chronic inflammatory demyelinating polyneuropathy. [WATCH TIME: 4 minutes]


David Lee Gordon, MD

Latest:

AUPN Leadership Minute Episode 27: Making Your Residents Happy

Episode 28 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University; and David Lee Gordon, MD, FAAN, FANA, FAHA, of University of Oklahoma. [WATCH TIME: 8 minutes]


Derek Ems, MPH, CPHQ

Latest:

Enhancing Methodologies for Comprehensive Patient Outcome Analysis in Epilepsy: Derek Ems, MPH, CPHQ

The health economics outcomes research specialist at UCB discussed the need for improved methodologies to have a more accurate analysis of patient outcomes beyond what administrative databases can provide. [WATCH TIME: 2 minutes]


Christos Lisgaras, PhD, MSc

Latest:

Exploring Animal Models to Inform Treatments for Alzheimer-Related Epileptic Activity: Christos Lisgaras, PhD, MSc

The research scientist at NYU Langone Health talked about findings from preclinical data investigating epileptiform activity in mouse models of Alzheimer disease, which were presented at AES 2023. [WATCH TIME: 4 minutes]


Carl V. Hill, PhD, MPH

Latest:

The Obstacle of Discrimination in Alzheimer Care: Carl V. Hill, PhD, MPH

The chief diversity, equity and inclusion officer at the Alzheimer’s Association discussed the findings of the association’s special edition of its annual Facts and Figures report.


Lori DePorter

Latest:

Patient Perspectives and the Importance of Advocacy and Support in Parkinson Disease: Lori DePorter

At ATMRD 2023, Lori DePorter, global ambassador for the PMD alliance, talked from the patient experience about the need for improved communication between care teams and support groups in Parkinson disease. [WATCH TIME: 3 minutes]


Luc Truyen, MD, PhD

Latest:

Unmet Needs in the Multiple Sclerosis Community: Luc Truyen, MD, PhD

The global head of Development and External Affairs-Neuroscience at Janssen Pharmaceutical discussed areas of multiple sclerosis research that need more attention.


Karen S. Ho, PhD

Latest:

Inclusive ALS Grant Expands Access to CNM-Au8 Therapy for ALS: Karen S. Ho, PhD

The vice president of translational medicine at Cene Nanomedicine talked about a recently funded grant that is focused on inclusivity and the collection of real-world data on the efficacy of CNM-Au8 in various stages of amyotrophic lateral sclerosis. [WATCH TIME: 7 minutes]


Darin Okuda, MD

Latest:

Advice for Clinical Management of Multiple Sclerosis

Dr Okuda shares his thoughts on the importance of patient dialogue in successful management of multiple sclerosis.


Sarah Honaker, PhD

Latest:

Dedicated Efforts for Improving Sleep Quality in Pediatrics, Adolescents: Sarah Honaker, PhD; Maureen McQuillan, PhD

The duo from Indiana University School of Medicine discussed the ongoing research initiatives to better understand sleep disorders among pediatrics, and ways to improve approaches like cognitive behavioral therapy. [WATCH TIME: 4 minutes]


Louise McCullough, MD, PhD

Latest:

AUPN Leadership Minute Episode 32: Succeeding in Basic Research as a Department

Episode 32 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the VHA and Albany Medical College; and Louise McCullough, MD, PhD, of the McGovern Medical School of UTHealth. [WATCH TIME: 5 minutes]


Irma Zhang, MD

Latest:

Promising Disease-Modifying Therapies in Parkinson Disease

Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.


Annabel Sorby-Adams, PhD

Latest:

Using a Portable Low Field MRI for Timely Diagnoses of Stroke: Annabel Sorby-Adams, PhD

The postdoctoral research fellow in neurology at Harvard Medical School talked about the potential of a portable low field MRI device to provide timely and cost-effective diagnoses for stroke. [WATCH TIME: 4 minutes]


Carlayne E. Jackson, MD, FAAN

Latest:

AUPN Leading Edge Episode 5: Neurology Chair, Academy President & Beyond

AUPN Leading Edge Episode 5 features Clifton L. Gooch, MD, and Carlayne E. Jackson, MD, FAAN, who discuss the “lessons learned” on the path toward leadership. [LISTEN TIME: 1 hour, 3 minutes]


Ambereen Mehta, MD

Latest:

Efforts to Expand Neuropalliative Care for Neuromuscular Disorders: Ambereen Mehta, MD, MPH

The palliative care physician and assistant professor of medicine at Johns Hopkins Bayview Medical Center discussed the types of resources clinicians can pull from to expand neuropalliative care for patients with neuromuscular disorders. [WATCH TIME: 3 minutes]


Matthew Schindler, MD, PhD

Latest:

Understanding the Associations of Stroke and COVID-19: Matthew Schindler, MD, PhD

The assistant professor of neurology at the University of Pennsylvania discussed stroke risk among patients with COVID-19 and the need to seek neurological consultation. [WATCH TIME: 3 minutes]


Hanna Huber, PhD

Latest:

Advancing Research With Remote Blood Collection for Alzheimer Biomarkers: Hanna Huber, PhD

The researcher in the department of neurochemistry at the University of Gothenburg in Sweden discussed bloodspot cards as a promising method for collecting blood samples in Alzheimer disease research. [WATCH TIME: 4 minutes]


John Kramer, PA-C

Latest:

Concluding Thoughts on Biosimilars in Multiple Sclerosis

Amy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.


Joe Burnett

Latest:

Easing Neurosurgery With Newly Approved SmartFrame OR Stereotactic System: Joe Burnett

The chief executive officer of ClearPoint Neuro discussed how the company’s SmartFrame OR Stereotactic System can facilitate neurosurgery and the next steps in integrating it into clinical settings. [WATCH TIME: 4 minutes]


Robert M. Pascuzzi, MD

Latest:

AUPN Leadership Minute Episode 8: Engaging Medical Students in Neurology – Part 1

Episode 8 of the AUPN Leadership Minute features Rohit Das, MD, of University of Texas Southwestern Medical Center at Dallas; and Robert M. Pascuzzi, MD, of Indiana University School of Medicine. [WATCH TIME: 4 minutes]


Christen Kutz, PhD, PA-C

Latest:

Managing MS in the Community: Advice and Resources

Advice and resources for colleagues, including community practitioners and neurologists, to encourage collaboration and best support for patients with multiple sclerosis (MS).


John Cerne, BS

Latest:

Stroke Intervention: A New Application of Interventional Neuroradiology

New training pathways are needed to close the gap between capable-physician supply and the growing demand for thrombectomy.


Irfan Qureshi, MD

Latest:

Utilizing the SCACOMS Composite Measure to Assess Treatment Benefit of Troriluzole in Spinocerebellar Ataxia: Irfan Qureshi, MD

The chief medical officer at Biohaven provided insight on its investigational spinocerebellar ataxia agent troriluzole, the advantages of the newly developed SCACOMS measure, and how the therapy stacks against natural history data. [WATCH TIME: 4 minutes]


Craig Zaidman, MD

Latest:

Telehealth Exam for SMA in Children and Adolescents

Crystal Proud, MD, demonstrates a typical neurological telehealth exam for pediatric SMA with one of her patients.


Walter Strapps, PhD

Latest:

Gene Editing as a Promising Treatment Approach for Duchenne Muscular Dystrophy: Walter Strapps, PhD

The chief scientific officer at Liberate Bio discussed how through the advancement of nonviral delivery technologies and nucleic acid therapeutics, genetic medicines can potentially bring relief to patients with Duchenne muscular dystrophy. [WATCH TIME: 5 minutes]


Todd Levine, MD

Latest:

Todd Levine, MD: Synuclein’s Role in Parkinson Disease Diagnosis

The chief medical officer of CND Life Sciences and medical director of Honor Health Neurology spoke to the role synuclein has played in advancing PD diagnosis.


Daniel Kantor, MD

Latest:

Remaining Questions Surrounding COVID-19 Vaccines in MS

Daniel Kantor, MD, discussed the data from his presentation at the 2022 CMSC annual meeting on COVID-19 vaccine response in patients with multiple sclerosis, and what questions are still lingering among the clinical community.

© 2024 MJH Life Sciences

All rights reserved.